Efficacy and Safety of Clinical Grade hVEGF-D ΔNΔC Gene Therapy Containing Residual Replication-Competent Adenoviruses

Biological bypass via induced angiogenesis by vascular endothelial growth factor D (VEGF-D) gene therapy is a new concept for the treatment of cardiac ischemia. Serotype 5 adenoviruses are used in ...